Proton Intelligence Secures $6.95M to Revolutionize Cardio-Kidney Care
Slice of Healthcare Team
01/08/2025
Key Highlights
- $6.95M Seed Financing led by SOSV, We Venture Capital, and others.
- CKM™ platform provides continuous potassium monitoring for cardio-kidney-metabolic diseases.
- Clinical studies underway for patients with CKD and ESRD.
- Transforming care by enabling timely data-driven decisions to prevent dyskalemia.
- Investors include SOSV, We Venture Capital, Tenmile, and others.
Source: Business Wire
Notable Quotes
Expert Insights
Share Your Expert Insights
Have relevant experience or professional perspective? Add your thoughtful insights to this article.
